The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold
Abstract
The ratio of $50,000 per quality-adjusted life-year (QALY) gained by using a given health care intervention has long served as a benchmark for the value of U.S. health care. But evidence suggests that it is too low and might best be thought of as an implied lower boundary.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Table 3 reports $100,000 as the suggested MCF per QALY based on the current trend of practice in the U.S. (Neumann, Cohen, & Weinstein, 2014).”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Neumann, Cohen, & Weinstein, 2014
Citations
Cites
Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard
Hirth, R. A., Chernew, M. E., Miller, E., Fendrick, A. M., & Weissert, W. G. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000310 · Cited by 850
Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
Grosse, S. D. (2008) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.8.2.165 · Cited by 637
Braithwaite, R. S., Meltzer, D. O., King, J. T., Leslie, D., & Roberts, M. S. (2008) · Medical Care · doi:10.1097/mlr.0b013e31815c31a7 · Cited by 579
Comparative Effectiveness and Health Care Spending — Implications for Reform
Weinstein, M. C., & Skinner, J. A. (2010) · New England Journal of Medicine · doi:10.1056/nejmsb0911104 · Cited by 247
Self-citationHow Much Are Americans Willing to Pay for a Quality-Adjusted Life Year?
Weinstein, M. C. (2008) · Medical Care · doi:10.1097/mlr.0b013e31816a7144 · Cited by 153
Self-citation
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
“Conventionally the threshold adopted by most agencies in the last couple of decades has been US $50,000 per year of life saved,(88) although either slightly lower (£30,000) or significantly higher levels (up to $150,000) have been proposed to account for inflation, specific national healthcare resources and other fact…”
BackgroundSanders, G. D., Neumann, P. J., Basu, A., Brock, D. W., Feeny, D., Krahn, M., Kuntz, K. M., Meltzer, D. O., Owens, D. K., Prosser, L. A., et al. (2016) · JAMA · doi:10.1001/jama.2016.12195 · Cited by 3,069
Self-citationThe economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Younossi, Z. M., Blissett, D., Blissett, R., Henry, L., Stepanova, M., Younossi, Y., Racila, A., Hunt, S., & Beckerman, R. (2016) · Hepatology · doi:10.1002/hep.28785 · Cited by 1,285
“QALYs lost were calculated as the difference between the projected QALYs in the NAFLD population and the projected QALYs in the general population, weighted by age, as sourced from the National Health Measurement study.((31,39-45)) This difference was then multiplied by the monetary value of a QALY.”
MethodJellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094
Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research
Woods, B., Revill, P., Sculpher, M., & Claxton, K. (2016) · Value in Health · doi:10.1016/j.jval.2016.02.017 · Cited by 884
“[5] Neumann PJ, Cohen JT, Weinstein MC.”
BackgroundInfluential
Metadata
- Authors
- Neumann, P. J., Cohen, J. T., & Weinstein, M. C.
- Affiliations
- Tufts Medical Center (US)
- Harvard University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-08-28
- Volume
- 371
- Issue
- 9
- Pages
- 796-797
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2058056848
- Cited by
- 2,249
- References
- 5
- Citations by year
- 2026: 122 · 2025: 152 · 2024: 160 · 2023: 162 · 2022: 212 · 2021: 242 · 2020: 245 · 2019: 239 · 2018: 222 · 2017: 184 · 2016: 162 · 2015: 123 · 2014: 15
- FWCI
- 400.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Keywords
- cost-effectiveness, quality-adjusted life years, health care value, health care spending, cost-effectiveness threshold
- MeSH terms
- Cost-Benefit Analysis, Health Policy, Humans, United States, Health Care Costs, Models, Economic, Quality-Adjusted Life Years
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold. https://app.cochat.ai/papers/10.1056/nejmp1405158
- The paper
- Neumann, P. J., Cohen, J. T., & Weinstein, M. C. (2014). Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold. New England Journal of Medicine. https://doi.org/10.1056/nejmp1405158
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.